Orchestra BioMed Holdings (OBIO)
NASDAQ:OBIO
US Market
Holding OBIO?
Track your performance easily

Orchestra BioMed Holdings (OBIO) Income Statement

56 Followers

Orchestra BioMed Holdings Income Statement

Last quarter (Q2 2024), Orchestra BioMed Holdings's total revenue was $778.00K, a decrease of -14.97% from the same quarter last year. In Q2, Orchestra BioMed Holdings's net income was $-15.98M. See Orchestra BioMed Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.08M$ 2.76M$ 3.53M--
Cost of Revenue
$ 166.00K$ 186.00K$ 211.00K--
Gross Profit
$ 1.91M$ 2.57M$ 3.32M--
Operating Expense
$ 60.39M$ 54.27M$ 36.19M$ 394.76K$ 179.99K
Operating Income
$ -58.29M$ -51.51M$ -32.66M$ -394.76K$ -179.99K
Net Non Operating Interest Income Expense
$ 3.94M$ 3.85M$ -50.00K$ 16.00K-
Other Income Expense
$ -1.77M$ -1.46M$ -1.00M--
Pretax Income
$ -55.53M$ -49.12M$ -33.61M$ -378.75K$ -179.99K
Tax Provision
-----
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -55.58M$ -49.12M$ -33.61M$ -378.75K$ -173.54K
Basic EPS
$ -1.56$ -1.48$ -0.17$ -0.02-
Diluted EPS
$ -1.56$ -1.48$ -0.17$ -0.02-
Basic Average Shares
$ 142.22M$ 33.23M$ 16.43M$ 20.45M$ 16.00M
Diluted Average Shares
$ 142.22M$ 33.23M$ 16.43M$ 20.45M$ 16.00M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 85.73M$ 54.27M$ 36.19M$ 394.76K$ 179.99K
Net Income From Continuing And Discontinued Operation
$ -55.58M$ -49.12M$ -33.61M$ -378.75K$ -173.54K
Normalized Income
$ -56.49M$ -38.81M---
Interest Expense
-----
EBIT
$ -58.31M$ -51.51M$ -32.66M$ -394.76K$ -179.99K
EBITDA
$ -57.26M$ -51.22M$ -32.44M$ -394.76K$ -179.99K
Currency in USD

Orchestra BioMed Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis